China Wins Fields Medal, GLP-1 Drugs Linked to Hair Loss, Nuvectis Drug Outperforms in PNH Trial, AI Reveals 3D Genome in Alzheimer, and more...
Published: July 27, 2026
Duration: 10:12
(0:10): Chinese Researchers Make History with Fields Medal Win for Pioneering Work in Mathematical Physics
(2:07): GLP-1 Agonists Linked to Increased Hair Loss Risk Compared to Other Diabetes Drugs
(3:50): China Approves Nuvectis' Ciprocopan for PNH, Outperforming Eculizumab in Phase 3 Trial
(6:00): AI and Multiomics Reveal 3D Genome Changes Driving Alzheimer's Progression
(8:23): OPTIMA Trial: Prosigna Test Safely Reduces Chemotherapy in High-Risk Breast Cancer Patients
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: BigGo Finance
(2:07): GLP-1 Agonists Linked to Increased Hair Loss Risk Compared to Other Diabetes Drugs
(3:50): China Approves Nuvectis' Ciprocopan for PNH, Outperforming Eculizumab in Phase 3 Trial
(6:00): AI and Multiomics Reveal 3D Genome Changes Driving Alzheimer's Progression
(8:23): OPTIMA Trial: Prosigna Test Safely Reduces Chemotherapy in High-Risk Breast Cancer Patients
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: BigGo Finance